Managed care

Maryland Care, Inc. Selects SS&C for Enhanced Insurance Investment Accounting

Retrieved on: 
Thursday, July 14, 2022

WINDSOR, Conn., July 14, 2022 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that MPC has chosen SS&C Singularity to support the operational, accounting and regulatory reporting needs of its investment portfolios. MPC will be transitioning from its current service provider to Singularity™, SS&C's innovative cloud-based investment accounting platform supported by an experienced team of professionals who have unmatched expertise in a wide range of asset classes, accounting treatments and insurance reporting requirements.

Key Points: 
  • MPC will be transitioning from its current service provider to Singularity, SS&C's innovative cloud-based investment accounting platform supported by an experienced team of professionals who have unmatched expertise in a wide range of asset classes, accounting treatments and insurance reporting requirements.
  • SS&C has a 36-year track record providing software and outsourcing services to the global insurance and asset management market.
  • "Singularity has significant momentum in the insurance space and we are delighted to welcome Maryland Care to SS&C's growing family of insurance clients," said Stan Szczepanik, Managing Director and Head of Insurance Solutions at SS&C.
  • MPC is a Managed Care Organization in Maryland participating in the Maryland Department of Health, Health Choice program.

Celularity Appoints Industry Leader Diane Parks to its Board of Directors

Retrieved on: 
Friday, June 3, 2022

FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appointment of Diane Parks to its Board of Directors.

Key Points: 
  • FLORHAM PARK, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a clinical-stage biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies, today announced the appointment of Diane Parks to its Board of Directors.
  • It is with great pleasure we welcome Diane to the Celularity Board of Directors during this exciting time of growth at the company, said Robert J. Hariri, M.D., Ph.D., founder, Chairperson and Chief Executive Officer of Celularity.
  • Parks, commented, I am very excited to join Celularitys Board of Directors and to help guide one of the most promising and innovative approaches to cellular therapeutics.
  • Parks joins the Celularity Board of Directors with more than 30 years of commercial experience in the pharmaceutical and biotechnology industries.

The OPEN MINDS I/DD Executive Summit Kicks Off The 2022 Strategy & Innovation Institute June 14 In New Orleans

Retrieved on: 
Monday, April 11, 2022

GETTYSBURG, Pa., April 11, 2022 /PRNewswire/ -- The 2022 OPEN MINDS I/DD Executive Summit: Innovations In Care Delivery For Consumers With I/DD & Complex Care Needs will take place as one of two executive summits to open the 2022 OPEN MINDS Strategy & Innovation Institute in New Orleans, LA on June 14, 2022.

Key Points: 
  • GETTYSBURG, Pa., April 11, 2022 /PRNewswire/ -- The 2022 OPEN MINDS I/DD Executive Summit: Innovations In Care Delivery For Consumers With I/DD & Complex Care Needs will take place as one of two executive summits to open the 2022 OPEN MINDS Strategy & Innovation Institute in New Orleans, LA on June 14, 2022.
  • The All-Access Institute Pass to The 2022 OPEN MINDS Strategy & Innovation Institute includes both the summit and seminars.
  • Registration is included in Elite-level subscriptions to the OPEN MINDS Circle market intelligence service.
  • For more information on the program, sponsorship opportunities, or media inquiries, contact the Executive Education and Events team, at 717-334-1329 or [email protected] .

U.S. Medical Management "USMM" is proud to announce new additions to executive leadership team

Retrieved on: 
Tuesday, April 5, 2022

TROY, Mich., April 5, 2022 /PRNewswire/ -- U.S. Medical Management "USMM", a recognized leader in providing high-quality, compassionate healthcare within proven care models that support complex and fragile individuals in the home setting, has appointed four experienced industry professionals to its leadership team. Shelly Martin has joined as Chief Operating Officer, Kristin Darby as Chief Information Officer, Jim Lydiard as Chief Strategy Officer, and Jonathan A. Meyers, FSA, MAAA as USMM Chief Actuary.

Key Points: 
  • "We are so pleased that top healthcare executives from around the country are joining our team at USMM.
  • Our new executive leadership team will build upon the incredible foundation and legacy of USMM to create a new, transformational care experience for all our patients and their families.
  • I couldn't be prouder of the energy, excitement, and experience that this new leadership team brings to USMM," said Adam Boehler, Executive Chairman of USMM and CEO of Rubicon Founders.
  • Kristin comes to USMM from Envision Healthcare in Nashville, TN where she served as the Enterprise Chief Information Officer.

Flume Health adds NextCare to its Flume Community™ Platform, Expanding In-Network Opportunities for Urgent Care Patients in Texas

Retrieved on: 
Wednesday, March 23, 2022

Flume Health and NextCare's arrangement allows middle market companies in all kinds of industries (that offer health plans powered by Flume) to add convenient and affordable access to urgent medical care for their employees and families.

Key Points: 
  • Flume Health and NextCare's arrangement allows middle market companies in all kinds of industries (that offer health plans powered by Flume) to add convenient and affordable access to urgent medical care for their employees and families.
  • "Flume Health has always been in the business of trying to make it easier for people to access care at a more reasonable price.
  • It's very much core to our mission, and it's what we've been doing from day one," saidCedric Kovacs-Johnson, CEO and founder, Flume Health.
  • NextCare operates 156 urgent care facilities in Arizona, Colorado, Kansas, Michigan, Missouri, New Mexico, North Carolina, Oklahoma, Texas, Virginia and Wyoming.

New Report Highlights Early Experiences with North Carolina's Transition to Medicaid Managed Care

Retrieved on: 
Monday, February 28, 2022

RALEIGH, N.C., Feb. 28, 2022 /PRNewswire/ -- Today, North Carolina for Better Medicaid (NCBM) and Health Management Associates (HMA) released a new report on North Carolina's transition to Medicaid Managed Care (MMC).

Key Points: 
  • RALEIGH, N.C., Feb. 28, 2022 /PRNewswire/ -- Today, North Carolina for Better Medicaid (NCBM) and Health Management Associates (HMA) released a new report on North Carolina's transition to Medicaid Managed Care (MMC).
  • HMA produced the report after interviewing key health care stakeholders in North Carolina, including advocates and care managers who work with Medicaid beneficiaries and have first-hand experience with the recent transition to Managed Care.
  • The report highlights these stakeholders' early experiences with Managed Care and identifies key successes and opportunities for going forward.
  • "This report reflects important feedback on Medicaid Managed Care in North Carolina from key stakeholders who have direct experience with the transition," said HMA Regional Vice President Kathleen Nolan.

Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

Retrieved on: 
Tuesday, February 15, 2022

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), today announced the appointment of prominent healthcare services industry leader and president of Care Solutions for Evernorth, Joan Harvey, to its Board of Directors.

Key Points: 
  • PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the Company or PAVmed), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), today announced the appointment of prominent healthcare services industry leader and president of Care Solutions for Evernorth, Joan Harvey, to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20220215005417/en/
    PAVmed appoints Joan Harvey to its Board of Directors.
  • PAVmeds groundbreaking health technologies combined with their strong clinical and research teams have tremendous potential to propel the health care industry forward, said Ms. Harvey.
  • Prior to joining Evernorth, Ms. Harvey served in senior leadership roles at Cigna, Medco Health Solutions Inc., WellPoint 360 Health.

BayCare Names New Vice President of Managed Care

Retrieved on: 
Thursday, February 10, 2022

CLEARWATER, Fla., Feb. 10, 2022 /PRNewswire/ -- BayCare Health System , a leading not-for-profit organization in West Central Florida, has named John W. Davis the new vice president of Managed Care.

Key Points: 
  • CLEARWATER, Fla., Feb. 10, 2022 /PRNewswire/ -- BayCare Health System , a leading not-for-profit organization in West Central Florida, has named John W. Davis the new vice president of Managed Care.
  • Davis, who was the vice president of accountable care strategies at UnitedHealthcare, is responsible for planning and directing all aspects of managed care at BayCare.
  • "We're thrilled to have Davis join BayCare," said Janice Polo, executive vice president and chief financial officer at BayCare.
  • Inpatient and outpatient services include acute care, primary care, imaging, laboratory, behavioral health, home care, and wellness.

Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director

Retrieved on: 
Thursday, January 27, 2022

PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (Interpace) a leader in enabling personalized medicine, is pleased to announce today that Vijay Aggarwal, Ph.D., has been appointed to the Interpace Board of Directors effective February 1, 2022.

Key Points: 
  • PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (Interpace) a leader in enabling personalized medicine, is pleased to announce today that Vijay Aggarwal, Ph.D., has been appointed to the Interpace Board of Directors effective February 1, 2022.
  • Dr. Aggarwal replaces Eric B. Lev, both designees of Ampersand 2018 Limited Partnership, a Series B Preferred stockholder of the Company.
  • We are very excited to welcome Dr. Aggarwal to our Board of Directors, stated Thomas Burnell, President and CEO of Interpace.
  • Pharma services, through Interpace Pharma Solutions, provides pharmacogenomics testing, genotyping, biorepository and other customized services to the pharmaceutical and biotech industries.

TRISTAR Acquires Risico Claims Management and Total Managed Care

Retrieved on: 
Monday, January 24, 2022

TRISTAR Insurance Group, Inc. (TRISTAR), the largest privately owned, independent third-party claims administrator in the United States, has agreed to acquire Risico Claim Management, Inc. and Risico Total Managed Care, Inc.s self-insured book of business.

Key Points: 
  • TRISTAR Insurance Group, Inc. (TRISTAR), the largest privately owned, independent third-party claims administrator in the United States, has agreed to acquire Risico Claim Management, Inc. and Risico Total Managed Care, Inc.s self-insured book of business.
  • We are very pleased to join the TRISTAR family, said Steven C. Wigh, Chief Operating Officer Risico Claims Management, Inc.
  • Tom Veale, President of TRISTAR, stated, We are excited to have the Risico and Total Managed Care teams join the TRISTAR organization.
  • Headquartered in Fresno, Risico has specialized in providing services to public agencies and food processors, delivering highly effective claims management, managed care/utilization review, bill review, and MPN management services.